James R Neal Akari Therapeutics PLC (AKTX) insider trading activity

AKTX Quotes by TradingView

James R Neal is of Akari Therapeutics Plc. Currently has a direct ownership of 36,271 shares of AKTX, which is worth approximately $46,064. The most recent transaction as insider was on Mar 06, 2025, when has been sold 4,464 shares (American Depositary Shares representing Ordinary Shares) at a price of $1.12 per share, resulting in proceeds of $4,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.3K
99.85% 3M change
n/a 12M change
Total Value Held $46,064

James R Neal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2025
BUY
Grant, award, or other acquisition
$4,999 $1.12 p/Share
4,464 Added 10.96%
36,271 American Depositary Sh...
Jan 09 2025
BUY
Grant, award, or other acquisition
-
8,000,000 Added 19.89%
32,216,000 Ordinary shares, par v...
Dec 23 2024
BUY
Grant, award, or other acquisition
-
2,000,000 Added 7.63%
24,216,000 Ordinary shares, par v...

Also insider at

XOMA
XOMA Corp Healthcare
CEO
PALI
PALISADE BIO, INC. Healthcare
Director
PCSA
Processa Pharmaceuticals, Inc. Healthcare
IGNYU
Ignyte Acquisition Corp. Financial Services
JRN

James R Neal

Emeryville, CA

Track Institutional and Insider Activities on AKTX

Follow Akari Therapeutics Plc and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AKTX shares.

Notify only if

Insider Trading

Get notified when an Akari Therapeutics PLC insider buys or sells AKTX shares.

Notify only if

News

Receive news related to Akari Therapeutics Plc

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AKTX